Publications – Requests for Information Responses

  • Potential Changes to the Policies for Oversight of DURC and the P3CO Policy Framework

    Publication Date: October 2023

    Potential Changes to the Policies for Oversight of Dual Use Research of Concern (DURC) and the Potential Pandemic Pathogen Care and Oversight (P3CO) Policy Framework: An EBRC Response to OSTP RFI 88 FR 60513.

  • Identifying Ambiguities, Gaps, Inefficiencies, and Uncertainties in the Coordinated Framework for the Regulation of Biotechnology

    Publication Date: February 2023

    Identifying Ambiguities, Gaps, Inefficiencies, and Uncertainties in the Coordinated Framework for the Regulation of Biotechnology: An EBRC Response to OSTP RFI 87FR77900

  • National Biotechnology and Biomanufacturing Initiative: An EBRC Response to OSTP RFI 87FR77901

    Publication Date: January 2023

  • Request for Information on Developing a Roadmap for the TIP Directorate at the National Science Foundation

    Publication Date: July 2023

    EBRC’s response to the request by the NSF for comments on the development of a roadmap to guide investment decisions of the newly formed TIP Directorate. We recommend prioritizing engineering biology research through infrastructure development, data programs, and equitable workforce initiatives to strengthen biotechnology translation and U.S. economic competitiveness. We also highlight the several crosscutting areas for investments where engineering biology overlaps with other TIP areas of interest, such as AI, materials science, climate change, and advanced robotics.


  • Request for Information on Future Topics for Workforce Development in Emerging Technology Career Pathways

    Publication Date: June 2023

    Response submitted by EBRC Director of Roadmapping and Education, Dr. Emily Aurand, to the request by NSF seeking novel approaches that lead to the recruitment of diverse and creative individuals into emerging technologies. This response provides strategic recommendations to increase the rate and composition of students enrolled in both traditional and non-traditional academic pathways to STEM and high-paying technology careers.


  • Public Comment on Oligo Synthesis Screening

    Publication Date: June 2022

    EBRC’s response to the request by HHS ASPR for comments on the Screening Framework Guidance for Providers and Users of Synthetic Oligonucleotides. EBRC convened a two-day workshop with stakeholders from academia, industry, and government to consider the Guidance, and the discussions that ensued formed the basis for this response.

  • Convention on Biological Diversity 2021 RFI

    Publication Date: June 2021

    EBRC’s response to the request from the Executive Secretariat to comment on the Convention on Biological Diversity Technical Series on Synthetic Biology to reflect advances in the rapidly growing field. As the regulatory landscape around synthetic biology emerges, it is crucial that these discussions are guided by science and expertise. In our submission, we provide detailed comments solicited and synthesized from our members— an international community of experts in synthetic biology from academia and industry.

  • NSF RFI on 2022-2026 Strategic Plan

    Publication Date: January 2021

    EBRC responds to the National Science Foundation’s Request for Information on its 2022-2026 Strategic Plan. EBRC addresses i) interests, values, and emerging science and policy issues; ii) US leadership in research and education; and iii) how the Strategic Plan can demonstrate the importance of fundamental research to the Nation.

  • National Defense Education Program 2021 RFI

    Publication Date: August 2020

    EBRC’s response to a Request for Information on behalf of the National Defense Education Program (NDEP) from the U.S. Department of Defense for the Office of the Under Secretary of Defense (Research & Engineering). This response: i) details the current status and limitations of the U.S. biotechnochnology education and workforce; ii) describes skillsets and capabilities needed for the future biotechnology workforce; iii) describes existing programs and models that can be leveraged or applied to support biotechnology education and workforce development, and the education levels where this would most impact; iv) recommends how to encourage the participation of minority and under-represented groups in biotechnology; and, v) describes metrics to measure progress and the level of investment necessary to ensure advancement.

  • HHS RFI on Review and Revision of the Screening Framework Guidance

    Publication Date: October 2020

    Many synthetic DNA synthesis companies screen their customers and the sequences they order in accordance with Guidance from the US Department of Health and Human Services. However, current guidance was issued in 2010 and thus is out of date. EBRC’s response to this RFI describes important considerations for updating the Guidance.

  • Back to top ⇑